{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T01:02:23Z","timestamp":1778461343045,"version":"3.51.4"},"reference-count":14,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.1542\/peds.2022-059491","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T18:21:20Z","timestamp":1663698080000},"source":"Crossref","is-referenced-by-count":7,"title":["Prioritizing Sickle Cell Disease"],"prefix":"10.1542","volume":"150","author":[{"given":"Lewis L.","family":"Hsu","sequence":"first","affiliation":[{"name":"aDivision of Pediatric Hematology\/Oncology, University of Illinois at Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Craig","family":"Hooper","sequence":"additional","affiliation":[{"name":"bDivision of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Schieve","sequence":"additional","affiliation":[{"name":"bDivision of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"2023110817364860600_B1","volume-title":"Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action","author":"National Academies of Sciences, Engineering, and Medicine","year":"2022"},{"issue":"11","key":"2023110817364860600_B2","doi-asserted-by":"crossref","first-page":"e1915374","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease","volume":"2","author":"Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023110817364860600_B3","unstructured":"National Heart Lung and Blood Institute, National Institutes of Health\n          . Evidence-based management of sickle cell disease: expert panel report, 2014. Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/evidence-based-management-sickle-cell-disease. Accessed September 9, 2022"},{"issue":"39","key":"2023110817364860600_B4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.15585\/mmwr.mm7139e1","article-title":"Use of recommended health care measures to prevent selected complications in children with sickle cell anemia\u2013selected States, 2019","volume":"71","author":"Schieve","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"2023110817364860600_B5","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1097\/MPH.0000000000002103","article-title":"Transcranial Doppler screening in a current cohort of children with sickle cell anemia: Results from the DISPLACE Study","volume":"43","author":"Kanter","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"2023110817364860600_B6","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/pds.4860","article-title":"National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997\u20132017","volume":"28","author":"Su","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"2023110817364860600_B7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamapediatrics.2019.1536","article-title":"A missed opportunity to address a national shame: the case of sickle cell disease in the United States","volume":"173","author":"Freed","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"2","key":"2023110817364860600_B8","doi-asserted-by":"crossref","first-page":"e28831","DOI":"10.1002\/pbc.28831","article-title":"Recommendation to reality: Closing the transcranial Doppler screening gap for children with sickle cell anemia","volume":"68","author":"Singh","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2023110817364860600_B9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s43058-021-00192-z","article-title":"Identified barriers and facilitators to stroke risk screening in children with sickle cell anemia: results from the DISPLACE consortium","volume":"2","author":"Phillips","year":"2021","journal-title":"Implement Sci Commun"},{"key":"2023110817364860600_B10","unstructured":"Kanter\n              J\n            . DISPLACE study team. DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment. Study findings from Parts 1\u20133, presented at NHLBI Annual Sickle Cell Disease meeting, Bethesda, MD, Aug 8\u201310, 2022. Day 1 videocast. Available at: https:\/\/videocast.nih.gov\/watch=45824. Accessed September 9, 2022"},{"issue":"6","key":"2023110817364860600_B11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jpepsy\/jsaa031","article-title":"A systematic review of medication adherence interventions in pediatric sickle cell disease","volume":"45","author":"Shih","year":"2020","journal-title":"J Pediatr Psychol"},{"issue":"8","key":"2023110817364860600_B12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01612840.2018.1443530","article-title":"Stigma of sickle cell disease: a systematic review","volume":"39","author":"Bulgin","year":"2018","journal-title":"Issues Ment Health Nurs"},{"issue":"6","key":"2023110817364860600_B13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0033354919881438","article-title":"Reducing health care disparities in sickle cell disease: a review","volume":"134","author":"Lee","year":"2019","journal-title":"Public Health Rep"},{"issue":"a","key":"2023110817364860600_B14","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12913-016-1595-z","article-title":"Evidence of non-response bias in the Press-Ganey patient satisfaction survey","volume":"16","author":"Tyser","year":"2016","journal-title":"BMC Health Serv Res"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2022-059491\/1563848\/peds_2022059491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2022-059491\/1563848\/peds_2022059491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T17:37:21Z","timestamp":1699465041000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/150\/6\/e2022059491\/189548\/Prioritizing-Sickle-Cell-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,11,16]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2022-059491","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"article-number":"e2022059491"}}